FDA Expands Use of Amgen ' s Blockbuster Drug FDA Expands Use of Amgen ' s Blockbuster Drug

Amgen Inc said on Friday that the U.S. Food and Drug Administration approved its drug, Xgeva, to prevent fractures in patients with multiple myeloma.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news